Grand Rapids, Mich. – – September 12, 2026 -- Shoulder Innovations, Inc. (NYSE: SI) has settled all outstanding patent litigation with Catalyst OrthoScience Inc., ending a legal dispute between the two shoulder-implant makers under confidential terms.
Shoulder Innovations resolves patent dispute with Catalyst OrthoScience under sealed terms
The settlement agreement closes all pending patent claims between Shoulder Innovations and Catalyst OrthoScience without disclosing financial or licensing terms.
CEO Rob Ball says the deal protects intellectual property tied to shoulder arthroplasty innovation
"We are pleased to have reached a resolution with Catalyst that provides an agreeable solution to this patent dispute," said Rob Ball, CEO of Shoulder Innovations. He said protecting intellectual property remains fundamental to ensuring continued investment benefits stakeholders, including surgeons and patients.
Company to continue focus on shoulder surgical care ecosystem after litigation closes
Shoulder Innovations, a commercial-stage medical technology company listed on the NYSE, said the resolution allows it to continue advancing shoulder arthroplasty implant systems and related surgical technologies.